Page 1681 - Clinical Small Animal Internal Medicine
P. 1681
Index 1619
mean arterial pressure (MAP) 406 acquired megaesophagus metabolic bone diseases 1521–1528
VetBooks.ir mechanical ileus 492–493, 493 congenital megaesophagus 558 fibrous osteodystrophy
calcium and phosphorus
558–559
mean electrical axis (MEA)
170–173, 171–172
physiology 1521–1522
gastrointestinal imaging
mechanical load 382–383, 388–389 475–476, 475–476 1522–1524
mechanical ventilation 393–402 idiopathic megaesophagus 559, 564 osteoporosis 1527–1528
adjustments to improve PaCO 2 398 motility disorders 564 rickets and osteomalacia
adjustments to improve PaO 2 398 treatment 559 1524–1527
airway pressure settings 395 meibomian gland adenoma/ metabolic diseases 677–683
airway suctioning 399 epithelioma 1261 amyloidosis 680–681
anesthesia 397 melamine urolithiasis 1132, 1132 copper storage diseases 681–683
catheter care 400 melanocytoma/melanoma cutaneous manifestations of systemic
complications 400–401 1347–1352 disease 1481–1484
eye care 400 anatomic site 1351–1352 forebrain disorders 776–778
general guidelines for initial diagnosis/pathology/molecular hepatic lipidosis secondary to
ventilator settings 396–397 biology 1347–1348 diabetes mellitus 678
goals 398 etiology/pathophysiology/ hepatic lipidosis/steatosis in
hemodynamic compromise 400 epidemiology 1347 cats 678–680
humidification 399 intraocular tumors 1264–1265, liver changes due to anemia and
hypoxemic respiratory failure 1264–1265 shock 680
397–398 male reproductive system liver in hyperthyroidism 678
indications for mechanical tumors 1313–1314 myelopathy 820
ventilation 393–394 ocular adnexal tumors 1262 oral cavity and salivary glands 544
initial stabilization 397–398 prognosis 1351–1352 vacuolar hepatopathy and liver
inspiratory:expiratory ratio and signalment 1347 changes in Cushing
respiratory rate setting 396 staging 1348, 1352, 1352 disease 677–678
nursing care 398–400, 402 treatment 1348–1351, 1350 vestibular disease 792
oral care 400 melanotroph cell marker 51 see also individual disorders
oxygen toxicity 401 MEN see multiple endocrine metaphyseal vessels 1513–1514
pneumothorax 401 neoplasia metastases
positive end‐expiratory pressure menace response 736–737 airway and lung cancers
settings 396 meningioma 761, 779, 1267 1277, 1279
recumbent patient care 400 meningitis 781–782 approach to the cancer
tidal volume settings 395 meningoencephalitis and patient 1199
tracheal tube management 399 meningomyelitis 795–801 biology of cancer and cancer
trigger settings 395–396 diagnosis 797–799 genetics 1207, 1210
ventilator‐associated epidemiology 796–797 bone and joint tumors
pneumonia 400 etiology/pathophysiology 1328–1329, 1331
ventilator breath types 394–395 795–796, 796 exocrine pancreatic
ventilator‐induced lung history and clinical signs 797 cancer 1294–1295
injury 401 prognosis 801 gynecologic cancers 1320
ventilator settings 394–397 signalment 797 hemangiosarcoma 1340–1342
weaning from mechanical treatment 799–801 hepatobiliary disease 668, 668
ventilation 401–402 meningoencephalitis of unknown hepatobiliary tumors 1304
see also individual techniques etiology (MUE) 799 intestinal cancers 1287, 1292
mediastinal neoplasia 335, meningoencephalitis of unknown origin liver disease 686
1236–1237, 1239 (MUO) 780–781, 799 male reproductive system
mediastinitis 477 mentation see neurologic assessment tumors 1312–1314
medical wipes 1398 Merkel cell tumors 1355 mammary cancer 1322–1324
Mediterranean spotted fever 937 mesenchymal tumors see sarcomas mast cell tumors 1360–1362
megacolon mesenteric fat necrosis 492, 492 melanoma 1347, 1351–1352
gastrointestinal imaging mesenteric lymphangiography oral tumors 1255
500–502, 502–503 342–343 pancreatic endocrine
motility disorders 576, 579 mesenteric portovenography 672 tumors 1298–1299
rectoanal diseases 612–613, 613 mesothelial cells 334 paraneoplastic syndromes 1222
megaesophagus 558–560 mesothelioma 339, 1272–1275 soft tissue sarcomas 1338
